European Commission To Allow Pre-MDD Non-CE Mark Devices Until 2001
This article was originally published in The Gray Sheet
Executive SummaryRecommendations concerning the use of non-CE marked devices after June 14 in member states have recently been upgraded to a "communication" by the European Commission, Smith & Nephew Director of European Regulatory Affairs Ian Cutler told attendees of a European device conference June 25 in Washington, D.C.
You may also be interested in...
Vertex is hoping for EU approval in Q4 of its cystic fibrosis triple combination therapy, Trikafta. It wants the same licence in the EU as it has in the US, where the product has already become a best seller for the company.
Sawai’s sales increased on the back of a good performance from recently-launched products in the first nine months of its financial year. However, given the competitive environment the Japanese company is continuing to stick to its full-year forecasts.